Synpromics' Private Equity - III Round

Synpromics raised a round of funding on September 04, 2018.

Synpromics is a developer of synthetic gene promoters, which are vital components in the research and development of gene-based medical treatments and therapies. Synpromics gives biological researcher…

Articles about Synpromics' Private Equity - III Round: